NAUTILUS BIOTECHNOLOGY INC. - COMMON STOCK

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results

27 фев 2025 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference

18 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 фев 2025 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award

31 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference

30 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2024 Financial Results

29 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024

08 окт 2024 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer

17 сен 2024 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

14 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Second Quarter 2024 Financial Results

30 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024

09 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

23 май 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

30 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024

11 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results

28 фев 2024 08:00:01 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

22 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

07 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award

30 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

01 ноя 2023 08:05:00 Источник Nasdaq GlobeNewswire

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

31 окт 2023 08:05:00 Источник Nasdaq GlobeNewswire